No Prescription » Prescription Drugs 7 » Fexigra Allegra
Fexofenadine is an antihistamine that provides relief of seasonal allergy symptoms such as runny or itchy nose sneezing itchy throat and watery itchy or red eyes. It is also used for hives.How to use Fexofenadine OralTake this medication by mouth usually once daily with or without food; or take as directed by your doctor.Taking fexofenadine with apple grapefruit or orange juice may decrease the absorption of this drug. Try to avoid taking fexofenadine with these types of fruit juices. If possible take this drug with water instead.Antacids containing aluminum and magnesium can decrease the absorption of this drug. Do not take antacids within 2 hours of taking this medication.Do not increase your dose or take this more often than directed. Dosage is based on your medical condition (e.g. kidney disease) and response to treatment.Do not take this medication for several days before allergy testing since test results can be affected. Consult your doctor or pharmacist for more information.Inform your doctor if your condition persists or worsens.Fexofenadine Oral is used to treat the following:Inflammation of the Nose due to an Allergy Seasonal Runny Nose Persistent Hives of Unknown CauseFexofenadine Oral may also be used to treat:Hives
Buy Fexigra Allegra and other Prescription Drugs 7 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Fexigra Allegra:
Product Type: Prescription Drugs 7
Fexigra ( Allegra Telfast Generic Fexofenadine )
Fexigra (Allegra Telfast Generic Fexofenadine)
Allegra Telfast Generic Fexofenadine
120mg 60 (2 x 30 Tablets) 120mg 30 Tablets 120mg 90 (3 x 30 Tablets) 180mg 90 (3 x 30 Tablets) 180mg 30 Tablets 180mg 60 (2 x 30 Tablets)
Allegra Telfast Generic Fexofenadine Fexigra

View more
Prescription Drugs 7
Previous Product Next Product
No Prescription:
NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.


|